Impact of obesity with or without hypertension on systemic haemodynamic and renal responses to lower body negative pressure

References

• Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23(11):1170–1178.
   PubMed Web of Science ®Google Scholar
• Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–814.
   PubMed Web of Science ®Google Scholar
• Johnson F, Cooke L, Croker H, et al. Changing perceptions of weight in Great Britain: comparison of two population surveys. BMJ. 2008; 337:a494.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• Haynes WG. Role of leptin in obesity-related hypertension. Exp Physiol. 2005;90(5):683–688.
   PubMed Web of Science ®Google Scholar
• Vaz M, Jennings G, Turner A, et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96(10):3423–3429.
   PubMed Web of Science ®Google Scholar
• Esler M, Straznicky N, Eikelis N, et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. 2006;48(5):787–796.
   PubMed Web of Science ®Google Scholar
• Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997;10(5 Pt 2):49S–55S.
   PubMed Web of Science ®Google Scholar
• Schwotzer N, Burnier M, Maillard M, et al. Sex and body mass index modify the association between Leptin and sodium excretion: a cross-sectional study in an African population. Am J Hypertens. 2019;32(11):1101–1108.
   PubMed Web of Science ®Google Scholar
• Convertino VA. Lower body negative pressure as a tool for research in aerospace physiology and military medicine. J Gravit Physiol. 2001;8(2):1–14.
   PubMedGoogle Scholar
• Wuerzner G, Chicléro A, Maillard M, et al. Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress. Kidney Int. 2004;65(1):238–244.
   PubMed Web of Science ®Google Scholar
• Wurzner G, et al. Renal and neurohormonal responses to increasing levels of lower body negative pressure in men. Kidney Int. 2001;60(4):1469–1476.
   PubMed Web of Science ®Google Scholar
• Wuerzner G, Chiolero A, Maillard M, et al. Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men. Kidney Int. 2005;68(2):688–694.
   PubMed Web of Science ®Google Scholar
• DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77(1):75–197.
   PubMed Web of Science ®Google Scholar
• Grouzmann E, Drouard-Troalen L, Baudin E, et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol. 2010;162(5):951–960.
   PubMed Web of Science ®Google Scholar
• Kairisto V, Koskinen P, Mattila K, et al. Reference intervals for 24-h urinary normetanephrine, metanephrine, and 3-methoxy-4-hydroxymandelic acid in hypertensive patients. Clin Chem. 1992;38(3):416–420.
   PubMed Web of Science ®Google Scholar
• Dunand M, et al. High-throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate. Anal Chem. 2013;85:3539–3544.
   PubMed Web of Science ®Google Scholar
• Magnin JL, Decosterd LA, Centeno C, et al. Determination of trace lithium in biological fluids using graphite furnace atomic absorption spectrophotometry: variability of urine matrices circumvented by cation exchange solid phase extraction. Pharm Acta Helv. 1996;71(4):237–246.
   PubMedGoogle Scholar
• Grassi G, Biffi A, Seravalle G, et al. Sympathetic neural overdrive in the obese and overweight state. Hypertension. 2019;74(2):349–358.
   PubMed Web of Science ®Google Scholar
• Waldstein SR, Burns HO, Toth MJ, et al. Cardiovascular reactivity and central adiposity in older African Americans. Health Psychol. 1999;18(3):221–228.
   PubMed Web of Science ®Google Scholar
• Barnes VA, Treiber FA, Davis H, et al. Central adiposity and hemodynamic functioning at rest and during stress in adolescents. Int J Obes. 1998;22(11):1079–1083.
   Web of Science ®Google Scholar
• Torres SJ, Turner AI, Jayasinghe SU, et al. The effect of overweight/obesity on cardiovascular responses to acute psychological stress in men aged 50–70 years. Obes Facts. 2014;7(6):339–350.
   PubMed Web of Science ®Google Scholar
• Enhörning S, Bankir L, Bouby N, et al. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort. Int J Obes (Lond). 2013;37(4):598–603.
   PubMed Web of Science ®Google Scholar
• Coiro V, Chiodera P. Effect of obesity and weight loss on the arginine vasopressin response to insulin-induced hypoglycaemia. Clin Endocrinol (Oxf)). 1987;27(2):253–258.
   PubMed Web of Science ®Google Scholar
• Chiodera P, Capretti L, Davoli C, et al. Effect of obesity and weight loss on arginine vasopressin response to metoclopramide and nicotine from cigarette smoking. Metab Clin Exp. 1990;39(8):783–786.
   PubMed Web of Science ®Google Scholar
• Schinke C, Hesse S, Rullmann M, et al. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls. Stress. 2019;22(1):93–102.
   PubMed Web of Science ®Google Scholar
• Llorens-Cortes C, Touyz RM. Evolution of a new class of antihypertensive drugs: targeting the brain renin-angiotensin system. Hypertension. 2020;75(1):6–15.
   PubMed Web of Science ®Google Scholar
• Ferdinand KC, Balavoine F, Besse B, et al. Efficacy and safety of firibastat, a first-in-class brain aminopeptidase A inhibitor, in hypertensive overweight patients of multiple ethnic origins. Circulation. 2019;140(2):138–146.
   PubMed Web of Science ®Google Scholar
• Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41(3 Pt 2):625–633.
   PubMed Web of Science ®Google Scholar
• Ribstein J, Du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension. 1995; 26(4):610–615.
   PubMed Web of Science ®Google Scholar
• Wuerzner G, Pruijm M, Maillard M, et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis. 2010;56(2):303–312.
   PubMed Web of Science ®Google Scholar
• Floras JS, Aylward PE, Mark AL, et al. Adrenaline facilitates neurogenic vasoconstriction in borderline hypertensive subjects. J Hypertens. 1990;8(5):443–448.
   PubMed Web of Science ®Google Scholar
• Frank H, Schobel H-P, Vitkowsky J, et al. Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress. Kidney Int. 2003;63(2):617–623.
   PubMed Web of Science ®Google Scholar